213 related articles for article (PubMed ID: 22261204)
1. Cytotoxic effects of 109 reference compounds on rat H4IIE and human HepG2 hepatocytes. III: Mechanistic assays on oxygen consumption with MitoXpress and NAD(P)H production with Alamar Blue™.
Schoonen WG; Stevenson JC; Westerink WM; Horbach GJ
Toxicol In Vitro; 2012 Apr; 26(3):511-25. PubMed ID: 22261204
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents.
Schoonen WG; de Roos JA; Westerink WM; Débiton E
Toxicol In Vitro; 2005 Jun; 19(4):491-503. PubMed ID: 15826807
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake.
Schoonen WG; Westerink WM; de Roos JA; Débiton E
Toxicol In Vitro; 2005 Jun; 19(4):505-16. PubMed ID: 15826808
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2.
Miret S; De Groene EM; Klaffke W
J Biomol Screen; 2006 Mar; 11(2):184-93. PubMed ID: 16314402
[TBL] [Abstract][Full Text] [Related]
5. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants.
Marroquin LD; Hynes J; Dykens JA; Jamieson JD; Will Y
Toxicol Sci; 2007 Jun; 97(2):539-47. PubMed ID: 17361016
[TBL] [Abstract][Full Text] [Related]
6. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
[TBL] [Abstract][Full Text] [Related]
7. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
8. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
9. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
[TBL] [Abstract][Full Text] [Related]
10. High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements.
Beckers S; Noor F; Müller-Vieira U; Mayer M; Strigun A; Heinzle E
Toxicol In Vitro; 2010 Mar; 24(2):686-94. PubMed ID: 19427895
[TBL] [Abstract][Full Text] [Related]
11. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells.
Noor F; Niklas J; Müller-Vieira U; Heinzle E
Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084
[TBL] [Abstract][Full Text] [Related]
12. The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity.
Hynes J; Hill R; Papkovsky DB
Toxicol In Vitro; 2006 Aug; 20(5):785-92. PubMed ID: 16386874
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the sensitivity of three sublethal cytotoxicity assays in human HepG2 cell line using water contaminants.
Jondeau A; Dahbi L; Bani-Estivals MH; Chagnon MC
Toxicology; 2006 Sep; 226(2-3):218-28. PubMed ID: 16930799
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays.
Hynes J; Nadanaciva S; Swiss R; Carey C; Kirwan S; Will Y
Toxicol In Vitro; 2013 Mar; 27(2):560-9. PubMed ID: 23147640
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity assay to evaluate the toxicity of an electrophilic reactive metabolite using glutathione-depleted rat primary cultured hepatocytes.
Fujimoto K; Kishino H; Yamoto T; Manabe S; Sanbuissho A
Chem Biol Interact; 2010 Dec; 188(3):404-11. PubMed ID: 20846519
[TBL] [Abstract][Full Text] [Related]
17. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
18. Primary culture of rat hepatocytes in 96-well plates: effects of extracellular matrix configuration on cytochrome P450 enzyme activity and inducibility, and its application in in vitro cytotoxicity screening.
Mingoia RT; Nabb DL; Yang CH; Han X
Toxicol In Vitro; 2007 Feb; 21(1):165-73. PubMed ID: 17141466
[TBL] [Abstract][Full Text] [Related]
19. The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development.
Westerink WM; Stevenson JC; Horbach GJ; Schoonen WG
Mutat Res; 2010 Feb; 696(1):21-40. PubMed ID: 20006733
[TBL] [Abstract][Full Text] [Related]
20. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
Atienzar F; Gerets H; Dufrane S; Tilmant K; Cornet M; Dhalluin S; Ruty B; Rose G; Canning M
Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
